KẾT QUẢ PHẪU THUẬT CẮT GAN CÓ NÚT ĐỘNG MẠCH GAN TRƯỚC MỔ ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN

Abstract

Objective: Describe the clinical and paraclinical characteristics and surgical results of patients with hepatocellular carcinoma (HCC) who underwent preoperative hepatic artery embolization. Method: A clinical intervention study was conducted on 46 with hepatocellular carcinoma (HCC) who underwent preoperative hepatic artery embolization. Results: The average age of the study group was 48,8±13 years, with a gender distribution of 80.4% male and 19.6% female. The majority of patients were discovered by chance, accounting for 47.8%, the proportion of patients with Child-Pugh A cirrhosis accounted for 89.1%, and there was 1 case of Child-Pugh B cirrhosis, accounting for 2.2%. The patients who had hepatic artery embolization once before surgery was 25 patients, accounting for 54.3%, and 21 patients had embolization more than once, accounting for 45.7%. The rate of incomplete tumor necrosis (less than 100%) was 36 cases, accounting for 78.3%, and 10 cases of complete tumor necrosis, accounting for 21.7%. The major liver resections was 60.9%, and the minor liver resections was 39.1%. The main postoperative complication was pleural effusion, accounting for 14.3%, the postoperative recurrence rate was 26.1%. There were 7 deaths at the end of the study, 6 deaths were due to postoperative recurrence. The average survival time after surgery was 44±2.75 months. Conclusion: Preoperative embolization of hepatic artery during liver resection for hepatocellular carcinoma is a safe method with low complication rate, helping to prolong liver survival and reduce postoperative recurrence rate.